Ra Medical's Electrophysiology Division Announces First Use of New Product
Ra Medical Systems, Inc. (RMED) has successfully announced the first use of its new LockeT device in a series of electrophysiology procedures. Shipping commenced on February 13, 2023, with approximately thirty devices utilized within the first week. The LockeT is designed for use in procedures involving venous punctures, particularly in atrial fibrillation and ventricular tachycardia treatments. CEO David Jenkins highlighted the device's potential to offer physicians innovative, cost-effective alternatives and improve patient outcomes across various procedures, including structural heart interventions.
- Successful initial use of LockeT device in 30 procedures.
- LockeT expands Ra Medical's product portfolio, offering new options for physicians.
- Device aims to improve patient outcomes in electrophysiology procedures.
- None.
Catheter Precision's LockeT Successfully Used in Series of Patients
FORT MILL, SC / ACCESSWIRE / March 6, 2023 / Ra Medical Systems, Inc. (RMED:NYSE/American) announced today that its wholly owned subsidiary, Catheter Precision, Inc., has announced the first series of procedures using the new LockeT device. Catheter Precision announced that shipping would begin on the week of February 13th and the first procedures would begin shortly thereafter. Within the first week, about thirty of the LockeT devices were used in electrophysiology procedures.
LockeT is used in procedures that require internal access via a venous puncture. These procedures are often associated with catheter insertion, such as those done during electrophysiology procedures like atrial fibrillation or ventricular tachycardias. The first thirty devices were used in the closure of percutaneous sites during procedures that included atrial fibrillation ablations, Watchman™ procedures, and a Lariat™ procedure. The Watchman and Lariat procedures are generally classified as structural heart procedures, as these devices are used for occlusion of the heart's left atrial appendage.
"Whenever a new product is used for the first time, it is exciting", said David Jenkins, CEO. "Gathering the initial feedback from physicians and seeing months of development work come to fruition is fulfilling not just for Catheter Precision, but for patients, because it provides physicians with new options that may provide more benefits. Adding LockeT to our product portfolio allows us to positively impact millions of patients and provide physicians with easy to use, cost effective alternatives to existing products and can be used in different procedures, with both small and large catheter insertion sites."
About Ra Medical Systems
Ra Medical, and its wholly owned subsidiary Catheter Precision, is an innovative U.S.-based medical device company bringing new solutions to market to improve the treatment of cardiac arrhythmias. It is focused on developing groundbreaking technology for electrophysiology procedures by collaborating with physicians and continuously advancing its products.
CONTACTS:
At the Company
David Jenkins
973-691-2000
mhuck@catheterprecision.com
SOURCE: Ra Medical Systems, Inc.
View source version on accesswire.com:
https://www.accesswire.com/741956/Ra-Medicals-Electrophysiology-Division-Announces-First-Use-of-New-Product
FAQ
What is the LockeT device used for by Ra Medical Systems (RMED)?
When did Ra Medical Systems begin shipping the LockeT device?
How many LockeT devices were used in initial procedures?
What types of procedures can utilize the LockeT device?
Who is the CEO of Ra Medical Systems (RMED)?
